Bimi International Medical Inc Cash Flow Conversion Efficiency
Bimi International Medical Inc cash flow conversion efficiency. Based on the latest financial reports, Bimi International Medical Inc (BIMI) has a cash flow conversion efficiency ratio of -0.146x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.48 Million) by net assets ($10.14 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Bimi International Medical Inc (2002–2022)
Cash flow conversion efficiency of Bimi International Medical Inc from 2002 to 2022. This chart illustrates how Bimi International Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Bimi International Medical Inc for real-time trading data and today's change.
Bimi International Medical Inc Cash Flow Conversion Ratio Explained
Bimi International Medical Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Bimi International Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bimi International Medical Inc ranked by their cash flow conversion efficiency. Also see BIMI stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Eason Technology Limited
NYSE:DXF
|
-0.103x |
|
Grand Vision Media Holdings PLC
LSE:GVMH
|
0.025x |
|
SCG PACKAGING -FGN- BA 1
F:5Y7A
|
0.038x |
|
American Shipping Company ASA
OL:AMSC
|
-0.201x |
|
Windtree Therapeutics Inc
NASDAQ:WINT
|
0.549x |
|
Captivision Inc
NASDAQ:CAPT
|
0.085x |
|
Mobile Global Esports Inc.
NASDAQ:MGAM
|
1.472x |
|
CuChi Commercial and Industrial Developing Investment JSC
VN:CCI
|
N/A |
Annual Cash Flow Conversion Efficiency for Bimi International Medical Inc (2002–2022)
The table below shows the annual cash flow conversion efficiency of Bimi International Medical Inc from 2002 to 2022. Review how much free cash does Bimi International Medical Inc generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $5.22 Million | $-10.26 Million | -1.966x | -1646.72% |
| 2021-12-31 | $11.34 Million | $-1.28 Million | -0.113x | +45.96% |
| 2020-12-31 | $16.89 Million | $-3.52 Million | -0.208x | +14.15% |
| 2019-12-31 | $8.51 Million | $-2.06 Million | -0.243x | -604.14% |
| 2018-12-31 | $9.99 Million | $-343.97K | -0.034x | -3.53% |
| 2017-12-31 | $27.30 Million | $-908.23K | -0.033x | -655.96% |
| 2016-12-31 | $26.71 Million | $159.83K | 0.006x | +107.35% |
| 2015-12-31 | $30.38 Million | $-2.47 Million | -0.081x | -156.42% |
| 2014-12-31 | $31.33 Million | $-995.08K | -0.032x | -213.36% |
| 2013-12-31 | $31.86 Million | $892.71K | 0.028x | -81.68% |
| 2012-12-31 | $29.81 Million | $4.56 Million | 0.153x | +81.39% |
| 2011-12-31 | $29.52 Million | $2.49 Million | 0.084x | -34.12% |
| 2010-12-31 | $26.26 Million | $3.36 Million | 0.128x | -9.94% |
| 2009-12-31 | $20.62 Million | $2.93 Million | 0.142x | +17756.84% |
| 2008-12-31 | $15.55 Million | $-12.51K | -0.001x | -100.95% |
| 2007-12-31 | $9.16 Million | $776.60K | 0.085x | +135.28% |
| 2006-12-31 | $5.23 Million | $-1.26 Million | -0.240x | -186.69% |
| 2005-12-31 | $-637.59K | $-176.68K | 0.277x | -68.78% |
| 2004-12-31 | $-409.66K | $-363.55K | 0.887x | +18.92% |
| 2003-12-31 | $-255.23K | $-190.47K | 0.746x | -68.76% |
| 2002-12-31 | $-178.41K | $-426.15K | 2.389x | -- |
About Bimi International Medical Inc
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical solution, and pharmaceutical and other healthcare products in the People's Republic of China and the United States. The company operates through four segments: Medical Devices; Healthcare Products; Wholesale Pharmaceuticals; and Pharmacy Retail. The Pharmacy Retail segment offers prescr… Read more